Artículo
Galigniana, M.D. "Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I" (2016) Current Molecular Pharmacology. 9(1):3-4
Estamos trabajando para incorporar este artículo al repositorio
Consulte la política de Acceso Abierto del editor
Registro:
| Documento: | Artículo |
| Título: | Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I |
| Autor: | Galigniana, M.D. |
| Filiación: | Instituto de Biología y Medicina Experimental-CONICET, Departamento de Química Biológica, Universidad de Buenos Aires, Buenos Aires, 1428, Argentina |
| Palabras clave: | fk 506 binding protein; glucocorticoid receptor; immunophilin; Rab protein; steroid receptor; immunophilin; ligand; alternative medicine; apoptosis; cell division; cytology; degenerative disease; drug protein binding; drug targeting; Editorial; human; Human immunodeficiency virus 1 infection; immunosuppressive treatment; ligand binding; major depression; mental disease; nerve regeneration; nonhuman; pleiotropy; priority journal; signal transduction; Streptomyces tsukubaensis; animal; antagonists and inhibitors; chemistry; drug development; metabolism; molecularly targeted therapy; protein conformation; Animals; Drug Discovery; Humans; Immunophilins; Ligands; Molecular Targeted Therapy; Protein Conformation |
| Año: | 2016 |
| Volumen: | 9 |
| Número: | 1 |
| Página de inicio: | 3 |
| Página de fin: | 4 |
| Título revista: | Current Molecular Pharmacology |
| Título revista abreviado: | Curr. Mol. Pharmacol. |
| ISSN: | 18744672 |
| CAS: | Immunophilins; Ligands |
| Registro: | https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18744672_v9_n1_p3_Galigniana |
Referencias:
- Heusler, K., Pletscher, A., The controversial early history of cyclosporin (2001) Swiss Med. Wkly, 131, pp. 299-302
- Ruegger, A., Kuhn, M., Lichti, H., Loosli, H.R., Huguenin, R., Quiquerez, C., von Wartburg, A., Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity (1976) Helv. Chim. Acta, 59, pp. 1075-1092
- Wenger, R.M., Synthesis of cyclosporine. Total synthesis of "Cyclosporin A" and "Cyclosporin H". Two fungal metabolites isolated from the species Tolypocladium Inflatum GAMS (1984) Helv. Chim. Acta, 67, pp. 502-525
- Borel, J.F., Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity (1976) Immunology, 31, pp. 631-641
- Borel, J.F., Feurer, C., Gubler, H.U., Stahelin, H., Biological effects of cyclosporin A: A new antilymphocytic agent (1976) Agents Actions, 6, pp. 468-475
- Tamura, K., Kobayashi, M., Hashimoto, K., Kojima, K., Nagase, K., Iwasaki, K., Kaizu, T., Niwa, M., A highly sensitive method to assay FK-506 levels in plasma (1987) Transplant Proc, 19, pp. 23-29
- Tanaka, H., Kuroda, A., Marusawa, H., Hashimoto, M., Hatanaka, H., Kino, T., Goto, T., Okuhara, M., Physicochemical properties of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis (1987) Transplant Proc, 19, pp. 11-16
- Goto, T., Kino, T., Hatanaka, H., Nishiyama, M., Okuhara, M., Kohsaka, M., Aoki, H., Imanaka, H., Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis (1987) Transplant Proc, 19, pp. 4-8
- Sehgal, S.N., Baker, H., Vezina, C., Rapamycin (AY-22, 989), a new antifungal antibiotic. II. Fermentation, isolation and characterization (1975) J. Antibiot. (Tokyo), 28, pp. 727-732
- Vezina, C., Kudelski, A., Sehgal, S.N., Rapamycin (AY-22, 989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle (1975) J. Antibiot. (Tokyo), 28, pp. 721-726
- Kluepfel, D., Baker, H.A., Piattoni, G., Sehgal, S.N., Sidorowicz, A., Singh, K., Vezina, C., Naphthyridinomycin, a new broad-spectrum antibiotic (1975) J. Antibiot. (Tokyo), 28, pp. 497-502
Citas:
---------- APA ----------
(2016) . Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I. Current Molecular Pharmacology, 9(1), 3-4.Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18744672_v9_n1_p3_Galigniana [ ]
---------- CHICAGO ----------
Galigniana, M.D. "Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I" . Current Molecular Pharmacology 9, no. 1 (2016) : 3-4.Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18744672_v9_n1_p3_Galigniana [ ]
---------- MLA ----------
Galigniana, M.D. "Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I" . Current Molecular Pharmacology, vol. 9, no. 1, 2016, pp. 3-4.Recuperado de https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18744672_v9_n1_p3_Galigniana [ ]
---------- VANCOUVER ----------
Galigniana, M.D. Editorial: Immunophilins, protein chemistry and cell biology of a promising new class of drug targets – Part I. Curr. Mol. Pharmacol. 2016;9(1):3-4.Available from: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_18744672_v9_n1_p3_Galigniana [ ]
